BPC-157: what the evidence actually shows
Peptide (research compound)
BPC-157 is one of the widest hype-to-evidence gaps in the wellness market: search interest exceeds 100,000 queries a month, while PubMed holds 227 indexed papers — and only 53 that involve humans at all. Almost everything known about it comes from rodent studies of tendon, gut and vascular healing. No controlled human trial has demonstrated a clinical benefit to date.
PubMed footprint (2026-08-29): 227 indexed publications, 53 involving humans (search: BPC-157 OR "BPC 157").
What it is
BPC-157 (“Body Protection Compound”) is a synthetic 15-amino-acid peptide fragment derived from a protein found in human gastric juice. Laboratories originally studied it in rats as a gut-protective agent; interest later spread to tendon-to-bone healing, muscle tears and vascular repair — again, overwhelmingly in rodents.
What the research actually shows
The animal literature is genuinely interesting: consistent signals of accelerated soft-tissue healing across many rodent models. The human literature is close to empty — the handful of human-linked records are mostly reviews, safety commentaries and case reports rather than controlled trials. If a seller cites “hundreds of studies”, ask how many were randomised trials in people; today the honest answer is none with published clinical endpoints.
Why it is popular anyway
Podcasts and biohacking forums adopted BPC-157 as an injury-recovery staple, and the injectable format gives it a clinical aura. Availability as an unregulated grey-market vial means quality, dose accuracy and sterility are unverified — independent tests of research-chemical peptides have repeatedly found under-dosed or mislabelled product.
Doses used in studies
Published rodent work typically used microgram-per-kilogram injections; there is no validated human dose because no regulator has ever reviewed one. Anything a vendor states is extrapolation, not an approved regimen.
Risks and open questions
Short-term tolerability reports in humans are anecdotal. Long-term safety, questions around growth-promoting signalling pathways, and interaction data simply do not exist. Athletes should know it is explicitly prohibited in competition.
FAQ
Is BPC-157 FDA-approved?
No. It is not approved by the FDA or any major regulator for any condition, and US compounding of it has been restricted.
Does BPC-157 work for tendon injuries in humans?
Unknown. Healing signals are consistent in rodent studies, but no controlled human trial has published clinical results.
Is BPC-157 legal for athletes?
It is on the WADA Prohibited List; using it can end a tested athlete's career.
Sources & further reading
→ Evaluating a clinic that sells this? Build a provider question list
Registry and literature counts retrieved 2026-08-29 (ClinicalTrials.gov API v2; PubMed E-utilities). Registration or publication volume measures research activity, not effectiveness or approval. Educational information — not medical advice; verify product, indication, legal pathway and evidence with an independent qualified physician. Page generated 2026-08-29. See our editorial standards.